18.02.2010 • News

Akzo Nobel Sees Increase in Q4 Operating Profit

Akzo Nobel has reported a 10% drop in revenue in 2009 to €13,893 million. However, the company is looking at a smaller net loss for Q4 2009 (€60 million) over the same period a year ago (€1.51 billion). The company has also reported a 7% decrease in Q4 sales. Q4 operating profit was up by 4%.

Akzo said that demand has recovered to year-ago levels, but "we believe the recovery is fragile and will be slow," CEO Hans Wijers said. "We continue to focus on customers, cost reduction and cash generation, but investments to capture growth will remain a priority - particularly in high growth markets."

AkzoNobel is looking at €540 million in cost cuts and synergies from its acquisition of ICI by the end of next year. Wijers also said the company is on track to meet its goal to achieve a target Ebitda margen of 14% by the end of 2011.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.